Dr. Donald F. Gleason, the Minnesota pathologist who developed the Gleason score that is now used almost universally in the U.S. to predict the likely outcome of prostate cancer, died Dec. 28 of a ...
Dr. Donald F. Gleason, the Minnesota pathologist who developed the Gleason score that is now used almost universally in the U.S. to predict the likely outcome of prostate cancer, died Dec. 28 of a ...
Using information gleaned from more than 20,000 men, researchers have affirmed the value of their alternative system for assessing the likelihood of growth and spread of prostate cancer. The new ...
For decades, the Gleason grading system has been the most widely used and accepted model for ranking the aggressiveness of prostate cancer. But a research team led by Jonathan Epstein from Johns ...
PHILADELPHIA -- Former President Joe Biden is being treated for prostate cancer, one of the most common cancers among men. Biden's cancer is an aggressive form of the disease, and has spread to his ...
A four-year study of more than 8,000 men between the ages of 50 to 75 who had an elevated risk for developing prostate cancer found that those who took the drug dutasteride (sold as Avodart) were less ...
A University of Chicago Medicine doctor is arguing that one of the most common types of cancer in men sometimes shouldn’t be called cancer at all — a stance that some say could save many patients from ...
ALERT. REACTION AND SUPPORT HAVE BEEN POURING IN FOLLOWING FORMER PRESIDENT JOE BIDEN’S PROSTATE CANCER DIAGNOSIS. AND THIS MORNING, SO IS AN EFFORT TO RAISE AWARENESS. LET’S LOOK AT THE NUMBERS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback